ライフサイエンスコーパス: common variable

1 A predictive model using five common variables (age, sex, race, eGFR, and dipstick pro

2 cell activation, and convey to patients with common variable immune deficiency (CVID) an increased ri

3 n MSH5 is associated with IgA deficiency and common variable immune deficiency (CVID) in humans.

4 Common variable immune deficiency (CVID) is a primary im

5 Common variable immune deficiency (CVID) is an assorted

6 ICOSL, or SH2D1, and are best classified as common variable immune deficiency (CVID), although other

7 eractor), is mutated in 10% of patients with common variable immune deficiency (CVID).

8 A 57-year-old woman with common variable immune deficiency and liver failure of u

9 mortality statistics from 473 subjects with common variable immune deficiency followed over 4 decade

10 Subjects with common variable immune deficiency may have mutations in

11 cy has been reported as a monogenic cause of common variable immune deficiency with features of immun

12 tivator and CAML interactor (TACI) result in common variable immune deficiency, a syndrome marked by

13 mechanism explaining the primary features of common variable immune deficiency, exquisite vulnerabili

14 ther disorders, including Evans syndrome and common variable immune deficiency, have been found to ha

15 ed immunodeficiency syndrome (AIDS); one had common variable immune deficiency; and 18 were receiving

16 ound that 4 of 19 unrelated individuals with common variable immunodeficiency (CVID) and 1 of 16 indi

17 Patients who have common variable immunodeficiency (CVID) and granulomatou

18 The population of patients with common variable immunodeficiency (CVID) comprises a hete

19 B cells of patients with common variable immunodeficiency (CVID) disorders displa

20 A subgroup of patients with common variable immunodeficiency (CVID) experience immun

21 ma cells, and almost 10% of individuals with common variable immunodeficiency (CVID) express either t

22 Although common variable immunodeficiency (CVID) has long been co

23 A subset of patients with common variable immunodeficiency (CVID) have debilitatin

24 Common variable immunodeficiency (CVID) is a disease tha

25 Common variable immunodeficiency (CVID) is a heterogeneo

26 Common variable immunodeficiency (CVID) is a heterogeneo

27 Common variable immunodeficiency (CVID) is a heterogeneo

28 Common variable immunodeficiency (CVID) is a syndrome ch

29 Common variable immunodeficiency (CVID) is an antibody d

30 Common variable immunodeficiency (CVID) is an antibody d

31 Common variable immunodeficiency (CVID) is an immune dis

32 Common variable immunodeficiency (CVID) is characterized

33 Common variable immunodeficiency (CVID) is characterized

34 Common variable immunodeficiency (CVID) is the commonest

35 Common variable immunodeficiency (CVID) is the primary i

36 Common variable immunodeficiency (CVID) patients can dev

37 A subgroup of common variable immunodeficiency (CVID) patients have di

38 in patients with autoimmune diseases and in common variable immunodeficiency (CVID) patients who are

39 B cells from common variable immunodeficiency (CVID) patients who hav

40 Most patients with common variable immunodeficiency (CVID) present with sev

41 the HVR of control patients to patients with common variable immunodeficiency (CVID) where the effect

42 B cells from patients with common variable immunodeficiency (CVID) who are heterozy

43 arisons between patients with GS, those with common variable immunodeficiency (CVID), and those with

44 Common variable immunodeficiency (CVID), characterized b

45 ts with multilineage cytopenias secondary to common variable immunodeficiency (CVID), Evans syndrome

46 al profile of CD4 T cells from patients with common variable immunodeficiency (CVID), including produ

47 Common variable immunodeficiency (CVID), the most freque

48 or PAD syndromes, with a particular focus on common variable immunodeficiency (CVID).

49 sess the genetic background of patients with common variable immunodeficiency (CVID).

50 lymphoid hyperplasia (PLH) in patients with common variable immunodeficiency (CVID).

51 Our index case was a patient with common variable immunodeficiency (CVID).

52 ACI) are found in 8% to 10% of subjects with common variable immunodeficiency (CVID).

53 s in these 2 genes have been associated with common variable immunodeficiency (CVID).

54 was highly similar to that of patients with common variable immunodeficiency and a defect in B-cell

55 ilin ligand interactor (TACI), contribute to common variable immunodeficiency and autoimmunity in hum

56 on, shown through the study of patients with common variable immunodeficiency and hyper IgM syndrome,

57 ustrate the heterogeneous molecular basis of common variable immunodeficiency and indicate the value

58 is review discusses the latest insights into common variable immunodeficiency and uses common variabl

59 everal primary immunodeficiencies, including common variable immunodeficiency and Wiskott-Aldrich syn

60 In humoral immunodeficiencies such as common variable immunodeficiency and X-linked agammaglob

61 and additional family members suffering from common variable immunodeficiency and/or selective IgA de

62 to common variable immunodeficiency and uses common variable immunodeficiency as a model to examine t

63 Patients with common variable immunodeficiency can be chronically infe

64 also been identified in some cases of severe common variable immunodeficiency disease.

65 Common variable immunodeficiency disorder (CVID) is the

66 le nucleotide polymorphisms in patients with common variable immunodeficiency disorder (CVID), which

67 mplex polygenic disorders, most commonly the common variable immunodeficiency disorders (CVIDs), pred

68 The European Common Variable Immunodeficiency Disorders registry was

69 Both Sjogren's syndrome and common variable immunodeficiency display clinical and im

70 Biallelic CD19 gene mutations cause common variable immunodeficiency in human subjects.

71 Common variable immunodeficiency is a rare immune defici

72 Common variable immunodeficiency is the most common prim

73 e defects affect a minority of patients with common variable immunodeficiency only, future genetic re

74 tterns in gut biopsies from individuals with common variable immunodeficiency or with HIV infection a

75 Using these assays, we could categorize common variable immunodeficiency patients into subgroups

76 children <2 y, the asplenic, and a subset of common variable immunodeficiency patients, are profoundl

77 rated IRF4 to be deregulated in B cells from common variable immunodeficiency patients, contributing

78 rstand the defective functions of B cells in common variable immunodeficiency patients.

79 reasons for an increased risk of lymphoma in common variable immunodeficiency patients.

80 tic assessment in paediatric patients with a common variable immunodeficiency phenotype, to establish

81 t activity might produce Omenn syndrome or a common variable immunodeficiency phenotype.

82 Newly identified disease genes within the common variable immunodeficiency population, have advanc

83 Common variable immunodeficiency represents the largest

84 ith unusually frequent bacterial infections, common variable immunodeficiency should always be consid

85 day period from a poliomyelitis patient with common variable immunodeficiency syndrome (a defect in a

86 ional features not typically associated with common variable immunodeficiency were diagnosed only lat

87 A 44-year-old woman with long-standing common variable immunodeficiency who was receiving intra

88 hich was previously implicated as a cause of common variable immunodeficiency with autoimmunity.

89 pecific antibody deficiencies; and potential common variable immunodeficiency), were retrieved.

90 n a clinical picture that is consistent with common variable immunodeficiency, and as many as 10% of

91 orders such as systemic lupus erythematosus, common variable immunodeficiency, and autoimmune lymphop

92 ysis of the proportion of any combination of common variable immunodeficiency, IgG deficiency, IgA de

93 -telangiectasia, Nijmegen-breakage-syndrome, common variable immunodeficiency, immunoglobulin A defic

94 present the different clinical phenotypes of common variable immunodeficiency, review recent genetic

95 t poliovirus infection in an individual with common variable immunodeficiency, using oral immunoglobu

96 nted with a phenotype resembling early-onset common variable immunodeficiency, while extra-immunologi

97 the diagnosis and treatment of patients with common variable immunodeficiency, with suggestions for t

98 tions in LRBA Biallelic LRBA mutations cause common variable immunodeficiency-8; however, NDM has not

99 s human PRKCD deficiency as a novel cause of common variable immunodeficiency-like B-cell deficiency

100 est risk was associated with T-cell PIDs and common variable immunodeficiency.

101 rom a poliomyelitis patient from Taiwan with common variable immunodeficiency.

102 fferentiation in familial IgA deficiency and common variable immunodeficiency.

103 responses are impaired in most patients with common variable immunodeficiency.

104 ession is similarly decreased in humans with common variable immunodeficiency.

105 ere, primary immunodeficiency reminiscent of common variable immunodeficiency.

106 ment similar to those found in patients with common variable immunodeficiency.

107 phoproliferative disease and severe cases of common variable immunodeficiency.

108 efects in patients previously diagnosed with common variable immunodeficiency.

109 ar antibodies, sinopulmonary infections, and common variable immunodeficiency.

110 ve been found to be mutated in patients with common variable immunodeficiency.

111 observation of large differences due to less common variables indicates the complex nature of the for

112 HC interfacial contacts in complexes bearing common variable segments and MHC allotypes.

113 Common variables that identify high-risk postoperative n